跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Mepraz - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Mepraz
Approved
STANDARD
Mepraz
Hizon Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
a5221e6ab98d0283
Company
Hizon Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
a5221e6ab98d0283
Drug Approval Philippines Name
Mepraz
Product Name
Mepraz
Registration Number
DRP-7916-01
Brand Name
Mepraz
Generic Name
Omeprazole
Dosage Form
Delayed Release Capsule
Dosage Strength
20 mg
Manufacturer
Hizon Laboratories, Inc.
Trader
S.V. More Pharma Corporation
Distributor
The Cathay Drug Co., Inc.
Issuance Date
25 March 2022
Expiry Date
05 January 2026
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
a5221e6ab98d0283
Type
Standard
Back to Philippines FDA Approvals